Caricamento...

Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCR

BACKGROUND: Patients with metastatic colorectal cancer can benefit from anti-EGFR therapy, such as cetuximab and panitumumab. However, colorectal cancers harboring constitutive activating mutations in KRAS, NRAS and BRAF genes are not responsive to anti-EGFR therapy. To select patients for appropria...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Med Genomics
Autori principali: Nagakubo, Yuki, Hirotsu, Yosuke, Amemiya, Kenji, Oyama, Toshio, Mochizuki, Hitoshi, Omata, Masao
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6849194/
https://ncbi.nlm.nih.gov/pubmed/31711486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12920-019-0610-8
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !